TREATMENT OF METASTATIC UVEAL MELANOMA - REVIEW AND RECOMMENDATIONS

被引:100
|
作者
ALBERT, DM
NIFFENEGGER, AS
WILLSON, JKV
机构
[1] UNIV HOSP CLEVELAND,IRELAND CANC CTR,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,CLEVELAND,OH 44106
关键词
CHEMOTHERAPY; CUTANEOUS MELANOMA; IMMUNOTHERAPY; MALIGNANT MELANOMA; UVEAL MELANOMA;
D O I
10.1016/S0039-6257(05)80024-4
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
This article reviews the published clinical responses of metastatic uveal melanoma and metastatic cutaneous melanoma with visceral involvement to current therapeutic protocols. Despite isolated patient responses to systemic treatment, no effective treatment currently exists for metastatic uveal melanoma. However, several new approaches involving interferons and interleukin and combination chemotherapy have shown some activity against metastatic cutaneous melanoma. The effectiveness against metastatic uveal melanomas has not been determined. A new approach to intrahepatic administration of chemotherapy also warrants further evaluation because of the high incidence of hepatic involvement with metastatic uveal melanoma. When an effective systemic treatment is found, early administration as an adjuvant to primary treatment may provide the best strategy for control of systemic spread.
引用
收藏
页码:429 / 438
页数:10
相关论文
共 50 条
  • [21] Uveal Melanoma Metastatic to the Liver: Treatment Trends and Outcomes
    Xu, Lucy T.
    Funchain, Pauline F.
    Bena, James F.
    Li, Manshi
    Tarhini, Ahmad
    Berber, Eren
    Singh, Arun D.
    OCULAR ONCOLOGY AND PATHOLOGY, 2019, 5 (05) : 323 - 332
  • [22] Immune Checkpoint Inhibitors in the Treatment of Metastatic Uveal Melanoma
    Kuo, J. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 60 - 61
  • [23] Novel combinatorial treatment option for metastatic uveal melanoma
    Frenkel, Shahar
    Shneor, Dudi
    Honigman, Alik
    Pe'er, Jacob
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [24] Ipilimumab for metastatic uveal melanoma
    Gilbert, Judith A.
    LANCET ONCOLOGY, 2013, 14 (10): : E394 - E394
  • [25] TREATMENT STRATEGIES FOR UVEAL MELANOMA: A SYSTEMATIC REVIEW
    Verma, R.
    Pillai, S.
    Telukuntla, V
    Khurana, I
    Ahuja, A.
    VALUE IN HEALTH, 2024, 27 (12) : S345 - S345
  • [26] UVEAL MELANOMA: A REVIEW OF THE EVIDENCE ON SURVEILLANCE AND SURVIVAL IN METASTATIC DISEASE
    Sax, James
    Campbell, Thomas
    Goodwin, Todd
    Warrier, Sunil
    Glasson, William
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 : 76 - 76
  • [27] Pembrolizumab as first-line treatment for metastatic uveal melanoma
    Ernesto Rossi
    Monica Maria Pagliara
    Daniela Orteschi
    Tommaso Dosa
    Maria Grazia Sammarco
    Carmela Grazia Caputo
    Gianluigi Petrone
    Guido Rindi
    Marcella Zollino
    Maria Antonietta Blasi
    Alessandra Cassano
    Emilio Bria
    Giampaolo Tortora
    Giovanni Schinzari
    Cancer Immunology, Immunotherapy, 2019, 68 : 1179 - 1185
  • [28] Prognosticators of first line treatment for metastatic uveal melanoma (MUM).
    Nicholas, Mathew
    Khoja, Leila
    Hogg, David
    Quirt, Ian
    Butler, Marcus
    Joshua, Anthony M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Systemic treatment of metastatic uveal melanoma - a silver lining on the horizon?
    Richly, H.
    Scheulen, M. E.
    Wiesweg, M.
    Abendroth, A.
    Schuler, M.
    Bauer, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 118 - 119
  • [30] Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
    Damato, Bertil E.
    Dukes, Joseph
    Goodall, Howard
    Carvajal, Richard D.
    CANCERS, 2019, 11 (07)